Biogen surges ahead of key FDA decision amid mixed views on potential Alzheimer’s therapy
Biogen (BIIB)rose ~5.0%on Friday tooutperform the broader marketfor the week as it awaits FDA approval for aducanumab, the experimental...
Full Article
Biogen surges ahead of key FDA decision amid mixed views on potential Alzheimer’s therapy
Upworthy
0 shares
1 views
You might like
Related news coverage
FDA Approves Highly Debated Alzheimer’s Drug
Watch VideoGovernment health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years,..
Newsy
US stocks close higher after President Biden declares infrastructure deal
4:05pm: US equities close higher US stocks closed higher after President Joe Biden declared that the White House struck an..
Proactive Investors